Citigroup’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,404,192
| Closed | -$30.5M | – | 5050 |
|
|
2017
Q2 | $30.5M | Buy |
1,404,192
+1,384,255
| +6,943% | +$30M | 0.03% | 306 |
|
|
2017
Q1 | $279K | Sell |
19,937
-19,162
| -49% | -$268K | ﹤0.01% | 2764 |
|
|
2016
Q4 | $733K | Buy |
39,099
+9,314
| +31% | +$175K | ﹤0.01% | 2615 |
|
|
2016
Q3 | $492K | Buy |
29,785
+13,166
| +79% | +$217K | ﹤0.01% | 2438 |
|
|
2016
Q2 | $223K | Sell |
16,619
-1,000
| -6% | -$13.4K | ﹤0.01% | 2787 |
|
|
2016
Q1 | $270K | Buy |
17,619
+17,600
| +92,632% | +$270K | ﹤0.01% | 3238 |
|
|
2015
Q4 | $0 | Buy |
19
+15
| +375% | – | ﹤0.01% | 5872 |
|
|
2015
Q3 | $0 | Sell |
4
-2,640
| -100% | – | ﹤0.01% | 5846 |
|
|
2015
Q2 | $54K | Buy |
2,644
+2,081
| +370% | +$42.5K | ﹤0.01% | 3697 |
|
|
2015
Q1 | $10K | Sell |
563
-11,925
| -95% | -$212K | ﹤0.01% | 4781 |
|
|
2014
Q4 | $204K | Buy |
12,488
+11,459
| +1,114% | +$187K | ﹤0.01% | 3146 |
|
|
2014
Q3 | $22K | Buy |
1,029
+750
| +269% | +$16K | ﹤0.01% | 4226 |
|
|
2014
Q2 | $6K | Sell |
279
-10,077
| -97% | -$217K | ﹤0.01% | 4782 |
|
|
2014
Q1 | $193K | Sell |
10,356
-5,914
| -36% | -$110K | ﹤0.01% | 2904 |
|
|
2013
Q4 | $164K | Buy |
16,270
+3,869
| +31% | +$39K | ﹤0.01% | 3310 |
|
|
2013
Q3 | $160K | Buy |
12,401
+162
| +1% | +$2.09K | ﹤0.01% | 2785 |
|
|
2013
Q2 | $145K | Buy |
+12,239
| New | +$145K | ﹤0.01% | 2985 |
|